NRSN icon

NeuroSense Therapeutics

7 hedge funds and large institutions have $1.87M invested in NeuroSense Therapeutics in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
AC
1
Armistice Capital
New York
$1.77M +$1.77M +1,584,000 New
MIH
2
Meitav Investment House
Israel
$44.8K -$11.2K -10,000 -20%
XT
3
XTX Topco
Cayman Islands
$36.6K +$36.6K +32,650 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$13.4K
Morgan Stanley
5
Morgan Stanley
New York
$1.68K
Carson Wealth (CWM LLC)
6
Carson Wealth (CWM LLC)
Nebraska
$1K
Qube Research & Technologies (QRT)
7
Qube Research & Technologies (QRT)
United Kingdom
$60
Renaissance Technologies
8
Renaissance Technologies
New York
-$129K -71,100 Closed
WP
9
Woodline Partners
California
-$35.6K -19,581 Closed
UBS Group
10
UBS Group
Switzerland
-$21.7K -11,928 Closed